News
PepGen slumps as FDA places hold on lead drug
Shares in PepGen fell sharply after the FDA placed a partial clinical hold on its lead drug for rare neuromuscular disease DM1.
News
Can GLP-1 drugs help tackle addiction?
New research has lent weight to the intriguing idea that GLP-1 agonists may help people with substance use disorders break their addiction.
News
Welsh firm Antiverse raises funds for AI antibody platform
Cardiff's Antiverse has raised $9.3m to develop its AI-based design platform for antibodies against hard-to-reach targets like GPCRs and ion channels.
News
Five projects share £100m UK-US Cancer Grand Challenges fund
Five scientific teams will receive up to £20m each in a new round of funding under the UK and US Cancer Grand Challenges initiative.
News
Moderna agrees $950m settlement of mRNA jab litigation
Moderna's settlement of patent litigation with Arbutus and Genevant over technology used in its Spikevax COVID vaccine could reach up to $2.25bn.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
